XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2018 $ 168,137 $ 17,772 $ (728) $ 38,448 $ 121,862 $ (9,217)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 5,864       5,864  
Other comprehensive income (loss), net of taxes 1,274         1,274
Common stock shares issued 13 9   4    
Restricted stock compensation expense 126     126    
Cash dividends declared (1,621)       (1,621)  
Ending Balance at Mar. 31, 2019 173,793 17,781 (728) 38,578 126,105 (7,943)
Beginning Balance at Dec. 31, 2018 168,137 17,772 (728) 38,448 121,862 (9,217)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 18,640          
Ending Balance at Sep. 30, 2019 186,074 17,843 (728) 39,418 135,351 (5,810)
Beginning Balance at Mar. 31, 2019 173,793 17,781 (728) 38,578 126,105 (7,943)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 6,466       6,466  
Other comprehensive income (loss), net of taxes 1,651         1,651
Common stock shares issued 149 11   138    
Restricted stock grants 391 39   352    
Restricted stock compensation expense 196     196    
Cash dividends declared (1,762)       (1,762)  
Ending Balance at Jun. 30, 2019 180,884 17,831 (728) 39,264 130,809 (6,292)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 6,310       6,310  
Other comprehensive income (loss), net of taxes 482         482
Common stock shares issued 166 12   154    
Cash dividends declared (1,768)       (1,768)  
Ending Balance at Sep. 30, 2019 186,074 17,843 (728) 39,418 135,351 (5,810)
Beginning Balance at Dec. 31, 2019 189,516 17,855 (728) 39,579 138,663 (5,853)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (1,223)       (1,223)  
Other comprehensive income (loss), net of taxes 3,333         3,333
Common stock shares issued 57,273 3,964   53,309    
Restricted stock compensation expense 262     262    
Cash dividends declared (2,167)       (2,167)  
Ending Balance at Mar. 31, 2020 246,994 21,819 (728) 93,150 135,273 (2,520)
Beginning Balance at Dec. 31, 2019 189,516 17,855 (728) 39,579 138,663 (5,853)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 11,345          
Ending Balance at Sep. 30, 2020 256,723 21,903 (728) 93,895 143,499 (1,846)
Beginning Balance at Mar. 31, 2020 246,994 21,819 (728) 93,150 135,273 (2,520)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 5,797       5,797  
Other comprehensive income (loss), net of taxes 900         900
Common stock shares issued 170 16   154    
Restricted stock grants 331 49   282    
Restricted stock compensation expense 166     166    
Cash dividends declared (2,168)       (2,168)  
Ending Balance at Jun. 30, 2020 252,190 21,884 (728) 93,752 138,902 (1,620)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 6,771       6,771  
Other comprehensive income (loss), net of taxes (226)         (226)
Common stock shares issued 162 19   143    
Cash dividends declared (2,174)       (2,174)  
Ending Balance at Sep. 30, 2020 $ 256,723 $ 21,903 $ (728) $ 93,895 $ 143,499 $ (1,846)